The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma (Q39349473)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 June 2006
edit
Language Label Description Also known as
English
The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma
scientific article published on 23 June 2006

    Statements

    The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit